Cite
MLA Citation
A C Moore et al.. “P411 Stable pharmacokinetics and biochemical markers of inflammatory bowel disease activity: Results from a real-world adalimumab biosimilar switching program.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i401–i402. http://access.bl.uk/ark:/81055/vdc_100150514503.0x00002c